Plan members who are residents of BC, SK and MB (pharmacare provinces) may be eligible for coverage under their provincial prescription drug program. Residents of
Private payer perspective matters:Guidance for developing a pharmaceutical budget impact analysis.Part 1 of a 2-part series. IntroductionAlthough Canada is recognised as having a publicly funded
Deadline date for switching Patients currently on an originator drug for which there is a biosimilar version for their medical condition must switch to the
